Masami Bessho

2.4k total citations
112 papers, 1.6k citations indexed

About

Masami Bessho is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Masami Bessho has authored 112 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 33 papers in Genetics and 28 papers in Molecular Biology. Recurrent topics in Masami Bessho's work include Acute Myeloid Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (23 papers) and Chronic Lymphocytic Leukemia Research (16 papers). Masami Bessho is often cited by papers focused on Acute Myeloid Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (23 papers) and Chronic Lymphocytic Leukemia Research (16 papers). Masami Bessho collaborates with scholars based in Japan, United States and Germany. Masami Bessho's co-authors include Itsuro Jinnai, Akira Matsuda, Fumiharu Yagasaki, I Murohashi, Kunitake Hirashima, Nozomi Niitsu, Hidekazu Kayano, Hideki Hirakata, Tadao Akizawa and Takashi Akiba and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Annals of Oncology.

In The Last Decade

Masami Bessho

105 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masami Bessho Japan 20 952 395 385 235 207 112 1.6k
Daniel Lysák Czechia 18 1.1k 1.1× 585 1.5× 671 1.7× 407 1.7× 65 0.3× 83 1.9k
Joo Seop Chung South Korea 23 415 0.4× 296 0.7× 247 0.6× 515 2.2× 60 0.3× 101 1.8k
David H. Henry United States 19 433 0.5× 234 0.6× 203 0.5× 619 2.6× 63 0.3× 49 1.7k
Nikolai A. Podoltsev United States 24 1.2k 1.3× 767 1.9× 534 1.4× 318 1.4× 38 0.2× 143 1.9k
Nigel Westwood United Kingdom 21 913 1.0× 767 1.9× 862 2.2× 480 2.0× 27 0.1× 68 2.2k
Conny J. van der Laken Netherlands 32 311 0.3× 506 1.3× 138 0.4× 365 1.6× 32 0.2× 100 2.8k
Torsten Keßler Germany 26 529 0.6× 950 2.4× 178 0.5× 685 2.9× 38 0.2× 92 2.1k
Chunde Bao China 31 305 0.3× 483 1.2× 283 0.7× 217 0.9× 153 0.7× 107 2.7k
Christoph Salat Germany 22 540 0.6× 470 1.2× 160 0.4× 564 2.4× 22 0.1× 63 2.0k
Binod Dhakal United States 24 1.2k 1.2× 792 2.0× 188 0.5× 852 3.6× 25 0.1× 163 1.9k

Countries citing papers authored by Masami Bessho

Since Specialization
Citations

This map shows the geographic impact of Masami Bessho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Bessho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Bessho more than expected).

Fields of papers citing papers by Masami Bessho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Bessho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Bessho. The network helps show where Masami Bessho may publish in the future.

Co-authorship network of co-authors of Masami Bessho

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Bessho. A scholar is included among the top collaborators of Masami Bessho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Bessho. Masami Bessho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishikawa, Maho, et al.. (2018). The Progression of Severe Aplastic Anemia to Hypoplastic Leukemia in a Long-Term Observation after the Administration of Pegylated rHuMGDF. Hematology Reports. 10(3). 7679–7679. 1 indexed citations
2.
Hirashima, Kunitake, et al.. (2015). Improvement in Anemia by Recombinant Human Erythropoietin in Patients with Myelodysplastic Syndrome and Aplastic Anemia. Contributions to nephrology. 88. 254–265.
3.
Niitsu, Nozomi, Mika Kohri, Yuki Hagiwara, et al.. (2010). Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B‐cell lymphoma. Hematological Oncology. 28(2). 68–74. 9 indexed citations
4.
Nakamura, Yuichi, Yasutaka Sato, Katsuhiko Yoshida, et al.. (2009). A molecular analysis of biclonal follicular lymphoma: further evidence for bone marrow origin and clonal selection. European Journal Of Haematology. 82(5). 398–403. 4 indexed citations
5.
Shimizu, Yoko, Naoki Takahashi, Mika Kohri, et al.. (2009). Primary cutaneous anaplastic large-cell lymphoma presenting with hemophagocytic syndrome: A case report and review of the literature. Leukemia Research. 34(2). 263–266. 12 indexed citations
6.
Suzuki, Masashi, Akira Saitō, Fumitake Gejyo, et al.. (2008). Baseline characteristics and anemia treatment for new hemodialysis patients. Nihon Toseki Igakkai Zasshi. 41(4). 251–254. 4 indexed citations
7.
Murohashi, I, Katsuhiko Yoshida, Fumiharu Yagasaki, et al.. (2006). Serum Levels of Thl/Th2 Cytokines, Angiogenic Growth Factors, and Other Prognostic Factors in Young Adult Patients with Hemophagocytic Syndrome. PubMed. 12(2). 71–74. 14 indexed citations
8.
9.
10.
Gejyo, Fumitake, Akira Saitō, Tadao Akizawa, et al.. (2004). 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients*. Therapeutic Apheresis and Dialysis. 8(6). 443–459. 58 indexed citations
11.
Sashida, Goro, Yoshikazu Ito, Akihiro Nakajima, et al.. (2003). Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia. Cancer Genetics and Cytogenetics. 141(2). 154–156. 5 indexed citations
12.
Matsuda, Akira, Katsuhiko Yoshida, Fumiharu Yagasaki, et al.. (2002). Long-term Follow-up of Patients with Aplastic Anemia and Refractory Anemia Responding to Combination Therapy with Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin. International Journal of Hematology. 76(3). 244–250. 5 indexed citations
13.
Yamamoto, Akiko, et al.. (2000). Granulocyte-colony stimulating factor induced intranuclear endonuclease in murine leukemia cell line. Leukemia Research. 24(12). 1033–1039. 4 indexed citations
14.
Itoh, Kazuyuki, Masatomo Takahashi, Fumiharu Yagasaki, et al.. (1999). A Neutropenic Acute Myeloid Leukemia Patient Complicated with Chronic Otitis Media due to Aspergillus niger and Yeast-like Fungi Caused by Superinfection. Kansenshogaku zasshi. 73(6). 618–622. 3 indexed citations
15.
Bessho, Masami, Kunitake Hirashima, Shigetaka Asano, et al.. (1997). Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony ‐ stimulating factor: a multicenter randomized controlled study. European Journal Of Haematology. 58(4). 265–272. 30 indexed citations
16.
17.
Suzuki, Toshiya, Masami Bessho, Kunitake Hirashima, et al.. (1991). Enhancement by transforming growth factor‐β 1 (TGF‐β 1) of the proliferation of leukemic blast progenitors stimulated with IL‐3. Journal of Cellular Physiology. 148(3). 396–403. 5 indexed citations
18.
Tamura, Mayuko, Kunihiro Hattori, Shun-ichi Hata, et al.. (1989). Effects of recombinant human granulocyte colony stimulating factor (rG-CSF) on murine myeloid leukemia: stimulation of proliferation of leukemic cells in vitro and inhibition of development of leukemia in vivo.. PubMed. 3(12). 853–8. 10 indexed citations
19.
Bessho, Masami, et al.. (1988). A new cell line of murine myeloid leukemia with A-type phosphoglycerate kinase as marker isoenzyme. Leukemia Research. 12(11-12). 911–916. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Lysák Breakdown of academic impact, for papers by Joo Seop Chung Breakdown of academic impact, for papers by David H. Henry Breakdown of academic impact, for papers by Nikolai A. Podoltsev Breakdown of academic impact, for papers by Nigel Westwood Breakdown of academic impact, for papers by Conny J. van der Laken Breakdown of academic impact, for papers by Torsten Keßler Breakdown of academic impact, for papers by Chunde Bao Breakdown of academic impact, for papers by Christoph Salat Breakdown of academic impact, for papers by Binod Dhakal
Rankless by CCL
2026